Global Transrectal Ultrasound (TRUS) Market Overview
The global transrectal ultrasound (TRUS) market is expected to grow at a steady CAGR of around 6% during the forecast period. The market growth is driven by the rising prevalence of prostate cancer, increasing awareness about early prostate screening, aging population, supportive reimbursement policies, and the growing number of TRUS procedures. However, high equipment and procedural costs, along with a shortage of skilled professionals, remain significant challenges limiting market expansion.
Key Request a free sample copy or view report summary: https://meditechinsights.com/transrectal-ultrasound-market/request-sample/
Overview
A transrectal ultrasound (TRUS) is a diagnostic imaging technique used to examine the prostate gland and nearby tissues using sound waves. During the procedure, a small probe is gently inserted into the rectum to capture high-frequency sound waves that generate real-time images of the prostate. These images help in identifying abnormalities such as infections, prostate enlargement, or tumors. TRUS is also widely used to guide prostate biopsies, enabling accurate tissue sampling for cancer diagnosis. The procedure is minimally invasive, typically lasting 15 to 30 minutes, and provides reliable diagnostic results with minimal discomfort. With continuous advancements in imaging technology, TRUS remains a preferred method in urology for its accuracy, patient comfort, and procedural efficiency.
Increasing Prevalence of Prostate Cancer
The growing incidence of prostate cancer, particularly among elderly males, is a major factor boosting the demand for transrectal ultrasound procedures. TRUS is a preferred diagnostic method due to its precision, non-invasiveness, and ability to provide real-time imaging for early detection and guided biopsies. According to the U.S. Centers for Disease Control and Prevention (CDC), over 255,000 new prostate cancer cases were reported in 2022, and 33,881 deaths occurred in 2023. The rising prevalence of prostate cancer, coupled with expanding prostate screening programs, public awareness initiatives, and an increase in urological disorders, is significantly contributing to the growth of the TRUS market.
Technological Advancements in TRUS Systems
Rapid technological advancements have transformed the transrectal ultrasound (TRUS) market, improving diagnostic accuracy, image clarity, and overall procedural efficiency. Modern TRUS systems provide high-resolution imaging and faster scans, reducing patient discomfort while enhancing visualization of the prostate, bladder, and rectum. The integration of artificial intelligence (AI) has further strengthened diagnostic capabilities by enabling automated detection and classification of abnormalities. AI-powered TRUS systems are now aiding in the early identification of conditions such as benign prostatic hyperplasia (BPH), rectal tumors, and pelvic infections. These innovations have expanded the utility of TRUS beyond urology into areas such as gastroenterology, supporting better biopsy guidance, treatment planning, and clinical outcomes.
“By enhancing collaboration, boosting productivity, and streamlining workflows between radiology and urology, caregivers can confidently provide their patients with the precise care they deserve,” said the Business Leader of Clinical Informatics at a leading MedTech company.
Competitive Landscape
The global transrectal ultrasound (TRUS) market is highly competitive, with key players including GE Healthcare, Koninklijke Philips N.V., KOELIS, FUJIFILM Corporation, Telemed Medical Systems, Exact Imaging, Hitachi Medical Systems, Mindray Medical International Limited, Siemens Healthineers AG, and Strata Imaging. Market participants are focusing on strategies such as product innovation, strategic collaborations, and geographical expansion to strengthen their market presence and capitalize on growing demand for advanced prostate imaging solutions.
Download pdf Brochure: https://meditechinsights.com/transrectal-ultrasound-market/request-sample/
About Us:
At Medi-Tech Insights, we are a global healthcare consulting firm committed to delivering premium insights and strategic solutions to help our clients navigate the complex and evolving healthcare landscape. Our team combines deep industry expertise with data-driven market intelligence to provide actionable insights that enable smarter decisions and sustainable success.
With a strong focus on innovation, quality, and impact, Medi-Tech Insights has become a trusted partner for leading healthcare investors and corporates across the globe.
